Dr John Leo Schomburg, MD in Minneapolis, MN - Medicare Urology

Dr John Leo Schomburg, MD is a medicare enrolled "Urology" physician in Minneapolis, Minnesota. He went to University Of Minnesota Medical School and graduated in 2012 and has 12 years of diverse experience with area of expertise as Urology. He is a member of the group practice Hennepin Healthcare System Inc and his current practice location is 715 S 8th St, Minneapolis, Minnesota. You can reach out to his office (for appointments etc.) via phone at (612) 873-6963.

Dr John Leo Schomburg is licensed to practice in Minnesota (license number 70366) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1396003323.

Contact Information

	Dr John Leo Schomburg, MD
	715 S 8th St, Minneapolis, MN 55404-1210
	(612) 873-6963
	Not Available

Physician's Profile

Full Name	Dr John Leo Schomburg
Gender	Male
Speciality	Urology
Experience	12 Years
Location	715 S 8th St, Minneapolis, Minnesota
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr John Leo Schomburg attended and graduated from University Of Minnesota Medical School in 2012

NPI Data:

NPI Number: 1396003323
Provider Enumeration Date: 04/27/2012
Last Update Date: 09/22/2023

Medicare PECOS Information:

PECOS PAC ID: 8628374147
Enrollment ID: I20211206002652

Medical Identifiers

Medical identifiers for Dr John Leo Schomburg such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1396003323	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	6717 (Wisconsin)	Secondary
208800000X	Urology	70366 (Minnesota)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Hennepin County Medical Center 1	Minneapolis, MN	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Hennepin Healthcare System Inc	4789684861	794

News Archive

HCV-infected donor kidneys are safe and functional one year post-transplantation

A recent analysis reveals that kidneys from donors infected with hepatitis C virus are now routinely used in transplants at many U.S. centers, and they are functioning well one year after transplantation.

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant, is providing an update regarding its efforts to file a Complete Response intended to gain U.S. Food and Drug Administration (FDA) marketing authorization of Surfaxin® for the prevention of respiratory distress syndrome (RDS) in premature infants.

UCLA-Harvard medication study highlights 3 types of confusing outcome measures

Studies about medications published in the most influential medical journals are frequently designed in a way that yields misleading or confusing results, new research suggests.

HTG, JWCI collaborate to develop new approaches for early stage primary cutaneous melanoma diagnosis

HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced it signed a collaboration agreement with the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California. Under the terms of the agreement, HTG and JWCI (Department of Molecular Oncology, Dave S. B. Hoon, Ph.D., Director) will collaborate to generate a novel mRNA signature that can measure the gene expression differences in melanoma and benign nevi using HTG's qNPA technology in classical surgical pathology samples.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr John Leo Schomburg allows following entities to bill medicare on his behalf.

Entity Name	Hennepin Healthcare System Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1033138136 PECOS PAC ID: 4789684861 Enrollment ID: O20070207000467

News Archive

HCV-infected donor kidneys are safe and functional one year post-transplantation

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

UCLA-Harvard medication study highlights 3 types of confusing outcome measures

Studies about medications published in the most influential medical journals are frequently designed in a way that yields misleading or confusing results, new research suggests.

HTG, JWCI collaborate to develop new approaches for early stage primary cutaneous melanoma diagnosis

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John Leo Schomburg is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr John Leo Schomburg, MD 701 Park Ave, Minneapolis, MN 55415-1623 Ph: (612) 873-3000	Dr John Leo Schomburg, MD 715 S 8th St, Minneapolis, MN 55404-1210 Ph: (612) 873-6963

News Archive

HCV-infected donor kidneys are safe and functional one year post-transplantation

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

UCLA-Harvard medication study highlights 3 types of confusing outcome measures

Studies about medications published in the most influential medical journals are frequently designed in a way that yields misleading or confusing results, new research suggests.

HTG, JWCI collaborate to develop new approaches for early stage primary cutaneous melanoma diagnosis

Urology Doctors in Minneapolis, MN

Victor Hugo Figueroa Arenas, MD, MHPE Urology Medicare: Medicare Enrolled Practice Location: 420 Delaware St Se, Minneapolis, MN 55455 Phone: 612-626-0697
Anup P. Ramani, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 516 Delaware Street Se, Clinic 1e, First Floor Pwb, Minneapolis, MN 55455 Phone: 612-636-6666
Paul Richard Bowlin, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2530 Chicago Ave Ste 550, Minneapolis, MN 55404 Phone: 612-813-8006
James Kyle Anderson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-672-7422
Dr. Ian Schwartz, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-810-0478
Hossein A Aliabadi, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2545 Chicago Ave, Suite 211, Minneapolis, MN 55404 Phone: 612-813-7900
David R Vandersteen, MD Urology Medicare: Medicare Enrolled Practice Location: 2530 Chicago Ave, #550, Minneapolis, MN 55404 Phone: 612-813-8000 Fax: 612-813-8005

Dr John Leo Schomburg, MD - Medicare Urology in Minneapolis, MN

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

HCV-infected donor kidneys are safe and functional one year post-transplantation

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

UCLA-Harvard medication study highlights 3 types of confusing outcome measures

HTG, JWCI collaborate to develop new approaches for early stage primary cutaneous melanoma diagnosis

Medicare Reassignments

HCV-infected donor kidneys are safe and functional one year post-transplantation

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

UCLA-Harvard medication study highlights 3 types of confusing outcome measures

HTG, JWCI collaborate to develop new approaches for early stage primary cutaneous melanoma diagnosis

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

HCV-infected donor kidneys are safe and functional one year post-transplantation

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

UCLA-Harvard medication study highlights 3 types of confusing outcome measures

HTG, JWCI collaborate to develop new approaches for early stage primary cutaneous melanoma diagnosis

Urology Doctors in Minneapolis, MN